Hemorrhagic Longitudinally Extensive Transverse Myelitis (LETM) as a First Presentation of Neuromyelitis Optica

Shima Jahani1, Fateme Jamshidi2, Abdorreza Naser Moghadasi1

  • 1Multiple Sclerosis Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran Iran.

Clinical Case Reports
|January 8, 2025
PubMed

Insights

A rare case of hemorrhagic longitudinally extensive transverse myelitis (LETM) presented as the first sign of Neuromyelitis Optica Spectrum Disorder. Despite aggressive treatment, the patient saw no improvement, highlighting diagnostic challenges and the need for prompt intervention.

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune disease targeting the central nervous system.
  • Longitudinally Extensive Transverse Myelitis (LETM) is a severe spinal cord inflammation, often a key feature in NMOSD.
  • Hemorrhagic myelitis, characterized by bleeding within the spinal cord, represents a particularly severe and challenging manifestation.

Purpose of the Study:

  • To report a rare case of hemorrhagic LETM as the initial presentation of NMOSD.
  • To emphasize the diagnostic difficulties associated with hemorrhagic LETM.
  • To underscore the critical need for timely and aggressive therapeutic interventions in such cases.

Main Methods:

  • Case report detailing a patient with initial symptoms of hemorrhagic LETM.
  • Review of diagnostic procedures and challenges encountered.
  • Analysis of treatment response and clinical outcome.

Main Results:

  • The patient presented with hemorrhagic LETM, later diagnosed as NMOSD.
  • Aggressive treatment did not lead to significant clinical improvement.
  • The case illustrates the complex diagnostic pathway for hemorrhagic LETM in NMOSD.

Conclusions:

  • Hemorrhagic LETM can be an initial manifestation of NMOSD.
  • Prompt diagnosis and intervention are crucial for managing hemorrhagic myelitis.
  • Diagnostic challenges in hemorrhagic LETM necessitate heightened clinical awareness.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53